References
- Accola, M. A., B. Strack, amd H. G. Gottlinger. 2000. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain. J Virol. Res. 74: 5395-5402 https://doi.org/10.1128/JVI.74.12.5395-5402.2000
- Baggiolini, M., B. Dewald, and B. Moser. 1994. Interleukin- 8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol. Res. 55: 97-179
- Brigati, C., M. Giacca, D. M. Noonan, and A. Albini. 2003. HIV Tat, its TARgets and the control of viral gene expression. FEMS Microbiol Lett. Res. 220: 57-65 https://doi.org/10.1016/S0378-1097(03)00067-3
- Clemens, M. J., M. Bushell, I. W. Jeffrey, V. M. Pain, and S. J. Morley. 2000. Translation initiation factor modifications and the regulation of protein synthesis in apoptotic cells. Cell Death Differ. Res. 7: 603-615 https://doi.org/10.1038/sj.cdd.4400695
- de la Fuente, C., F. Santiago, L. Deng, C. Eadie, I. Zilberman, K. Kehn, A. Maddukuri, S. Baylor, K. Wu, C. G. Lee, A. Pumfery, and F. Kashanchi. 2002. Gene expression profile of HIV-1 Tat expressing cells: A close interplay between proliferative and differentiation signals. BMC Biochem. 3: 14
- Ensoli, B., L. Buonaguro, G. Barillari, V. Fiorelli, R. Gendelman, R. A. Morgan, P. Wingfield, and R. C. Gallo. 1993. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. Res. 67: 277-287
- Fotheringham, J., M. Mayne, C. Holden, A. Nath, and J. D. Geiger. 2004. Adenosine receptors control HIV-1 Tat-induced inflammatory responses through protein phosphatase. Virol. Res. 327: 186-195 https://doi.org/10.1016/j.virol.2004.07.007
- Gallo, R. C., A. Burny, and D. Zagury. 2002. Targeting Tat and IFN(alpha) as a therapeutic AIDS vaccine. DNA Cell Biol. Res. 21: 611-618 https://doi.org/10.1089/104454902760330147
- Gerszten, R. E., E. A. Garcia-Zepeda, Y. C. Lim, M. Yoshida, H. A. Ding, M. A. Gimbrone Jr., A. D. Luster, F. W. Luscinskas, and A. Rosenzweig. 1999. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nat. Res. 398: 718-723
- Gottlinger, H. G., J. G. Sodroski, and W. A. Haseltine. 1989. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86: 5781-5785
- Khan, R. and D. P. Giedroc. 1992. Recombinant human immunodeficiency virus type 1 nucleocapsid (NCp7) protein unwinds tRNA. J. Biol. Chem. Res. 267: 6689-6695
- Kim, B. S., S. J. Kang, S. B. Lee, W. Hwang, and K. S. Kim. 2005. Simple method to correct gene-specific dye bias from partial dye swap information of a DNA microarray experiment. J. Microbiol. Biotechnol. 15: 1377-1383
- Koch, A. E., P. J. Polverini, S. L. Kunkel, L. A. Harlow, L. A. DiPietro, V. M. Elner, S. G. Elner, and R. M. Strieter. 1992. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Sci. Res. 258: 1798-1801
- Ko, K. S., J. Y. Lee, J. H. Song, J. Y. Baek, W. S. Oh, J. S. Chun, and H. S. Yoon. 2006. Screening of essential genes in Staphylococcus aureus N315 using comparative genomics and allelic replacement mutagenesis. J. Microbiol. Biotechnol. 16: 623-632
- Lane, B. R., K. Lore, P. J. Bock, J. Andersson, M. J. Coffey, R. M. Strieter, and D. M. Markovitz. 2001. Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy. J Virol. Res. 75: 8195-8202 https://doi.org/10.1128/JVI.75.17.8195-8202.2001
- Larsen, C. G., A. O. Anderson, E. Appella, J. J. Oppenheim, and K. Matsushima. 1989. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Sci. Res. 243: 1464-1466
- Lee, N., R. J. Gorelick, and K. Musier-Forsyth. 2003. Zinc finger-dependent HIV-1 nucleocapsid protein-TAR RNA interactions. Nucleic Acids. Res. 31: 4847-4855 https://doi.org/10.1093/nar/gkg679
- Lee, S. G., Y. J. Kim, S. I. Han, Y. K. Oh, S. H. Park, Y. H. Kim, and K. S. Hwang. 2006. Simulation of dynamic behavior of glucose- and tryptophan-grown Escherichia coli using constraint-based metabolic models with a hierarchical regulatory network. J. Microbiol. Biotechnol. 16: 993-998
- Li, S., N. Sonenberg, A.-C. Gingras, M. Peterson, S. Avdulov, V. A. Polunovsky, and P. B. Bitterman. 2002. Translational control of cell fate: Availability of phosphorylation sites on translational repressor 4E-BP1 governs its proapoptotic potency. Mol. Cell. Biol. Res. 22: 2852-2861
- Lockhart, D. J., H. Dong, M. C. Byrne, M. T. Follettie, M. V. Gallo, M. S. Chee, M. Mittmann, C. Wang, M. Kobayashi, H. Horton, and E. L. Brown. 1996. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat. Biotechnol. Res. 14: 1675-1680 https://doi.org/10.1038/nbt1296-1675
- Neuveut, C., R. M. Scoggins, D. Camerini, R. B. Markham, and K. T. Jeang. 2003. Requirement for the second coding exon of Tat in the optimal replication of macrophage-tropic HIV-1. J. Biomed. Sci. Res. 10: 651-660 https://doi.org/10.1007/BF02256316
- Schena, M., D. Shalon, R. W. Davis, and P. O. Brown. 1995. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Sci. Res. 270: 467-470
- Tan, A., P. Bitterman, N. Sonenberg, M. Peterson, and V. Polunovsky. 2000. Inhibition of Myc-dependent apoptosis by eukaryotic translation initiation factor 4E requires cyclin D1. Oncogene Res. 19: 1437-1447 https://doi.org/10.1038/sj.onc.1203446
- Wain-Hobson, S., P. Sonigo, O. Danos, S. Cole, and M. Alizon. 1985. Nucleotide sequence of the AIDS virus, LAV. Cell. Res. 40: 9-17 https://doi.org/10.1016/0092-8674(85)90303-4
- Yoshimura, T., K. Matsushima, S. Tanaka, E. A. Robinson, E. Appella, J. J. Oppenheim, and E. J. Leonard. 1987. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc. Natl. Acad. Sci. USA 84: 9233-9237